| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $403.1M | +21.3% |
| R&D Expense | $47.9M | +3.5% |
| SG&A Expense | $165.8M | +1.7% |
| Operating Income | $60.3M | +10.8% |
| Pre-tax Income | -$20.8M | +59.7% |
| Income Tax | $1.8M | — |
| Net Income | -$22.7M | +56.2% |
| EPS (Basic) | -$0.11 | +60.7% |
| EPS (Diluted) | -$0.11 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $167.9M | +16.0% |
| Accounts Receivable | $140.2M | +74.9% |
| Inventory | $105.1M | +11.3% |
| Current Assets | $462.6M | +36.9% |
| Total Assets | $465.9M | +35.5% |
| Current Liabilities | $300.8M | +22.2% |
| Total Liabilities | $767.9M | +4.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.1M | +44.6% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $36.2M | -58.2% |
| Free Cash Flow | -$13.1M | +45.4% |
| +60.7% |
| Stockholders' Equity |
| -$302.0M |
| +22.3% |